NASDAQ:CBLI
Delisted
Cleveland BioLabs Stock News
$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022
Cleveland BioLabs (NASDAQ:CBLI) Stock Price Down 9.8%
05:40am, Saturday, 18'th Jul 2020
Shares of Cleveland BioLabs, Inc. (NASDAQ:CBLI) fell 9.8% during mid-day trading on Thursday . The company traded as low as $2.36 and last traded at $2.57, 9,782 shares changed hands during mid-day tr
Cleveland BioLabs (NASDAQ:CBLI) Share Price Crosses Above Two Hundred Day Moving Average of $1.91
01:56am, Tuesday, 14'th Jul 2020
Cleveland BioLabs, Inc. (NASDAQ:CBLI) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.91 and traded as high as $
Global Biodefense Market (2020 to 2030) - by Product, Sales Channel, Application, and Region - ResearchAndMarkets.com
12:00am, Monday, 06'th Jul 2020
The
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.32%
12:00am, Monday, 29'th Jun 2020
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.32%
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.84%
12:00am, Friday, 26'th Jun 2020
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.84%
Cleveland BioLabs Closes $3.175 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
08:05pm, Wednesday, 03'rd Jun 2020
BUFFALO, NY / ACCESSWIRE / June 3, 2020 / Cleveland BioLabs, Inc. (CBLI), today announced the closing of its previously announced registered direct offering to several institutional and accredited inv
20 Healthcare Stocks Moving In Tuesday's Pre-Market Session
11:32am, Tuesday, 02'nd Jun 2020Cleveland BioLabs Announces $3.175M Registered Direct Offering Priced At-The-Market
12:49pm, Monday, 01'st Jun 2020Cleveland BioLabs Announces $3.175 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
12:30pm, Monday, 01'st Jun 2020
BUFFALO, NY / ACCESSWIRE / June 1, 2020 / Cleveland BioLabs, Inc. (CBLI), today announced that it has entered into definitive agreements with several institutional and accredited investors for the iss
Cleveland BioLabs S-3 Shows Registration For $50M Mixed Securities Shelf
09:14pm, Thursday, 21'st May 2020Cleveland BioLabs Q1 EPS $(0.800) Down From $(0.110) YoY, Sales $156.000K Down From $227.576K YoY
01:06pm, Friday, 15'th May 2020Cleveland BioLabs Reports First Quarter 2020 Financial Results and Development Progress
01:00pm, Friday, 15'th May 2020
BUFFALO, NY / ACCESSWIRE / May 15, 2020 / Cleveland BioLabs, Inc. (NASDAQ:CBLI) today reported financial results and development progress for the first quarter ended March 31, 2020. Cleveland BioLabs
